Skip to main content
. 2018 Jan 24;50(4):1362–1377. doi: 10.4143/crt.2017.353

Table 1.

In vitro anti-tumor effect of curcumin and its analogues against SLMT-1, HKESC-2, and KYSE-270 ESCC cell lines

IC50 (μM)
SLMT-1 HKESC-2 KYSE-270
Curcumin 14.25±0.36 13.15±0.49 14.43±0.11
SSC-3 2.75±0.44 1.75±0.05 0.96±0.04
SSC-5 1.22±0.41 0.47±0.06 1.21±0.18
SSC-6 > 5 2.57±1.07 4.52±0.91
SSC-8 2.98±1.18 2.33±1.04 2.98±0.81
SSC-9 3.13±0.59 1.82±0.16 1.86±0.29
SSC-10 2.39±1.13 1.82±0.16 1.61±0.18
SSC-19 1.53±0.43 1.18±0.55 1.24±0.12
SSC-20 3.16±0.63 1.67±0.42 3.56±0.10

ESCC, esophageal squamous cell carcinoma.